Cumberland Pharmaceuticals Inc. (CPIX) Return on equity 2016–2025
Cumberland Pharmaceuticals Inc. (CPIX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-11.4%FY2025 · since FY2016: -1.3% → -11.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.4% | +17.0 pp |
| FY2024 | -28.4% | -7.1 pp |
| FY2023 | -21.2% | -5.9 pp |
| FY2022 | -15.4% | -7.2 pp |
| FY2021 | -8.2% | -1.1 pp |
| FY2020 | -7.1% | -0.2 pp |
| FY2019 | -6.9% | +5.5 pp |
| FY2018 | -12.5% | -0.0 pp |
| FY2017 | -12.4% | -11.2 pp |
| FY2016 | -1.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CPIX financial trends
CPIX RevenueCPIX Net incomeCPIX Net marginCPIX Gross profitCPIX Gross marginCPIX Operating incomeCPIX Operating marginCPIX Operating cash flowCPIX Free cash flowCPIX Capital expendituresCPIX Stock buybacksCPIX Dividends paidCPIX Total assetsCPIX Total liabilitiesCPIX Shareholders’ equityCPIX overview →